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Superior vena cava (SVC) syndrome is a known but rare complication of pacemaker lead implantation, accounting for
approximately less than 0.5% of cases. Its pathophysiology is due to either infection or endothelial mechanical stress,
causing inflammation and fibrosis leading to thrombosis, and therefore stenosis of the SVC. Due to the various
risks including thrombo-embolic complications and the need to provide symptomatic relief, medical and surgical
interventions are sought early. We present the case of a 48-year Caucasian male who presented with localised swelling
and pain at the site of pacemaker implantation. Inflammatory markers were normal, but diagnostic imaging revealed
three masses along the pacemaker lead passage. A surgical approach using cardiopulmonary bypass and circulatory
arrest was used to remove the vegetations. Culture from the vegetations showed Staphylococcus epidermidis. The
technique presented here allowed for safe and effective removal of both the thrombus and infected pacing leads, with
excellent exposure and minimal post-procedure complications.
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Superior Vena Cava (SVC) syndrome is an extremely
rare but serious complication of pacemaker-lead im-
plantation, characterised by symptomatic occlusion of
the SVC [1,2]. Malignancy is considered to be the most
common aetiology of SVC syndrome, but benign iatro-
genic causes from intravascular devices (catheters, car-
diac defibrillators and pacemaker wires) are becoming
increasingly recognised [3]. Symptoms classically include
neck, facial and/or upper limb swelling, along with other
neurological complaints, which may all be exacerbated
by different postures.
The frequency of pacemaker-induced SVC syndrome
is difficult to ascertain; it can either be acute or chronic,
with many patients being asymptomatic. The asympto-
matic prevalence may be as high as 30% of all patients
[4], with partial or complete venous obstruction. This is* Correspondence: t.athanasiou@imperial.ac.uk
2Department of Surgery and Cancer, Imperial College London, 10th Floor,
QEQM Building, St Mary’s Hospital Campus, South Wharf Road, London W2
1NY, UK
Full list of author information is available at the end of the article
© 2014 Kokotsakis et al.; licensee BioMed Cen
Creative Commons Attribution License (http:/
distribution, and reproduction in any medium
Domain Dedication waiver (http://creativecom
article, unless otherwise stated.due to the development of an adequate venous collateral
circulation. However, symptomatic cases of SVC ob-
struction from transvenous pacemaker implantation are
more rare and are thought to account for less than 0.5%
of all patients [5,6]. This can develop over a time period
of between 2 days and 206 months [2]. The mortality
associated with benign causes of SVC syndrome is low,
however those patients who do become symptomatic are
often debilitated by it, thus necessitating intervention.
The pathophysiology behind this phenomenon is likely
endothelial disruption from mechanical stress or infec-
tion of the pacemaker leads, leading to inflammation
and fibrosis and subsequently, thrombosis [7,8]. Several
predictors may increase the propensity of thrombus
formation and venous occlusion: upgrade of pacemaker
devices; more than one pacemaker lead; device and/or
lead infection; severed pacemaker leads [2,7,9].
The potential to develop SVC occlusion is a recognised
indication for lead extraction. Other indications for device
and lead extraction have been set out by the Heart Rhythm
Society Expert Consensus [10]. These are broadly cate-
gorized into four main categories: a) infection includingtral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
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bosis or venous stasis including superior vena cava sten-
osis or occlusion with limiting symptoms; c) functional
and d) non-functional leads [10,11]. With respect to
pacemaker-related infections, the incidence varies greatly,
with some reporting rates as low as 0.13%, but this can be
as high as 19.9% [12]. Staphylococcus species account for
the majority of infections (Staphylococcus aureus and
Staphylococcus epidermidis), while other gram-negative
bacilli, Enterococcus faecalis, Pseudomonas aeruginosa,
Candida-species have also been implicated [12].
Management of pacemaker lead thrombosis can be
either medical or surgical. Medical forms of management
include anti-coagulation or thrombolysis, while surgical
interventions rely on percutaneous endovascular interven-
tion or lead extraction [13]. Lead extraction methods have
evolved from transvenous procedures to laser-assisted ex-
traction and in much more severe cases, the use of cardio-
pulmonary bypass. In this report and literature review, we
present a case of SVC syndrome caused by pacemaker
lead infection, which was managed with cardiopulmonary
bypass and circulatory arrest.
Case presentation
A 48 year-old Caucasian man attended outpatients’ clinic
with a six-month history of localised swelling and pain at
the site of his pacemaker implantation, particularly upon
abduction of his right arm. He had twenty years previously
undergone implantation of a VVI (ventricle; ventricle;
inhibited) pacemaker due to sick sinus syndrome. Two
years prior to his current attendance, the pacemaker
was altered due to battery depletion and concomitantlyFigure 1 Transverse plane image of contrast-enhanced CT scan demoupgraded to a DDD (dual-chamber; dual-chamber; dual
triggered and inhibited) device.
Physical examination revealed venous distension of the
neck, upper chest and arms, but was otherwise normal.
His electrocardiogram (ECG) was normal and he was
not pacemaker dependent. Biochemical laboratory inves-
tigations including inflammatory markers were normal,
and blood cultures were negative.
A trans-esophageal echocardiography (TEE) identified
three masses: a 40 × 18 mm mass at the atrial lead during
its passage along the superior vena cava (SVC), which it
occluded; a second 12 × 11 mm mass at the atrial surface
of the ventricular lead; a third 5 × 5 mm mass during pas-
sage through the tricuspid valve. An open foramen ovale
was further identified. Subsequently, contrast-enhanced
chest computed tomography (CT) confirmed the TEE
findings (Figure 1). On the basis of these findings a
provisional diagnosis of concurrent SVC syndrome from
infected vegetations of the pacing leads was made.
The presence of the large masses in the right heart cavi-
ties posed a risk of acute embolism, and so any attempt of
transvenous retraction could not be made safely. It was
therefore decided that the entire pacemaker system should
be surgically explanted. The patient was transferred to the
cardiac surgery department for an urgent surgical extrac-
tion of the leads and masses, as well as closure of the fossa
ovale.
Surgical procedure
In the first instance the infected right infra-clavicular
pacemaker pocket was opened, the generator was re-
moved and endocardial leads were mobilized. A mediannstrating two pacemaker leads within the SVC.
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along with its confluence with the inferior vena cava
(IVC) was dissected out. Heparin was administrated
(300 μ/kg) and cardiopulmonary bypass (CPB) was estab-
lished via the ascending aorta, innominate vein (Figure 2)
and inferior vena cava (IVC). Myocardial protection was
achieved with anterograde cold crystalloid cardioplegia
(Custodiol 25 ml/kg) directly into the aortic root. The pa-
tient was cooled to a temperature of 26 degrees before
commencing total circulatory arrest. The innominate vein
and IVC were snared to isolate the right atrium and the
thrombosed superior vena cava (SVC). The right atrium
was opened and the incision was extended for 2 cm to-
wards the right lateral wall of the SVC. The atrial and ven-
tricular endocardial leads were carefully removed along
with the adherent vegetations (Figures 3 and 4). The SVC
was then completely thrombo-endartectomized. The pa-
tent foramen ovale was closed. The right atrial and SVC
incision was closed with a running 4-0 polypropylene su-
ture after de-airing the right side of the heart. CPB flow
was re-instigated with a total circulatory arrest time of
38 minutes. Temporary epicardial pacing wires were
placed in the right ventricle and right atrium. After a
period of reperfusion and rewarming the patient was
weaned from CPB. Wounds were closed after thorough
antibiotic irrigation. The post-operative course was un-
complicated without the need for a further new pace-
maker insertion.
Histological examination of the second mass that oc-
cluded the SVC was characterised as a thrombus, whereas
the other two masses were identified as vegetations. Cul-
ture from the vegetations and the pacemaker pocket
yielded Staphylococcus epidermidis. This was treated withFigure 2 Cannulation of the innominate vein.daptomycin 500 mg daily for six weeks. Post-operative
cultures were negative, and post-operative CT showed a
clear SVC (Figure 5). The patient was discharged after
7 days, with antibiotics for 6 weeks. Following the surgical
procedure, there was substantial improvement in the pa-
tient’s clinical condition and the obstructive symptoms of
the SVC syndrome subsided.
Conclusions
We present an emergency case of SVC syndrome caused
by transvenous pacemaker lead infection and throm-
bosis. A surgical approach, which required circulatory
arrest and cardiopulmonary bypass, was required due to
the extent of thrombus formation within the SVC. Be-
cause of the high risk of thrombo-embolic complications
and because of symptom progression, prompt investiga-
tion and management was required.
Other surgical techniques including transveonous dila-
tors, retrieval baskets and laser-assisted extraction have
been previously described [14]. These percutaneous inter-
ventions are more frequently utilised. Byrd et al. report
their experiences of intravascular extraction of 3,540 in-
fected or problematic pacemaker leads, and demonstrate
an overall major complication rate of 1.4%, with minor
complications (including arrhythmias, pneumothorax,
minor pericardial effusion) occurring in 2.3%. Importantly,
they highlight greater risk with increasing number of leads
and lesser experience [15]. Kennergren et al. described
European experiences of laser-assisted extraction whereby
there was extraction failure in 5.7%, and a total complica-
tion rate of 5.1% of the total 383 lead extractions [16]. Per-
cutaneous stenting is another form of management for
device-related SVC syndrome in order to retain the leads
Figure 3 Extracted pacemaker leads.
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term outcomes. Long-term data and efficacy for this modal-
ity, however, remains unknown. The choice between such
procedures and a surgical approach remains unclear, but
guidelines suggest that in those with larger masses, surgical
extraction remains more desirable [10].
Our conventional approach of cardiopulmonary bypass
and myocardial arrest allows both direct visualisation and
complete removal of all pacemaker components (in-
cluding leads) whilst avoiding dissemination of large
thrombus. Wilhelm and colleagues present their experi-
ences of 8 lead removals using extracorporeal circulation,Figure 4 Extracted thrombus.and after a follow-up period of more than 18 months, 6 of
8 patients were alive and infection-free [17]. They also de-
scribe advantages of: less injury to heart structures; less
vegetations from blood flow, which might otherwise cause
mechanical stress; and the ability to perform concomitant
procedures if required [17]. Okada et al. describe their re-
cent experiences of 6 such procedures, with all surviving
the follow-up period and one having a recurrence of infec-
tion [18]. Abad et al. demonstrate the well-tolerated use
of cardiopulmonary bypass amongst seven patients with
pacemaker infections; four with Staphylococcus epidermi-
dis, two with Staphylococcus aureus and one Pseudomonas
Figure 5 Post-operative 3-dimensional CT-imaging demonstrating complete clearance the SVC obstruction.
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follow-up period greater than two years and new epi-
cardial devices inserted [19]. The use of cardiopulmonary
bypass has been successfully described is several other re-
ports, [20-23] with some reporting in the context of endo-
carditis or septicaemia, and one with further tricuspid
valve debridement following endocarditis [23].
Our technique is novel in its cannulation of the innom-
inate vein to complete the bypass circuit due to the extent
of vegetations within the SVC. Previous practises have uti-
lised the saphenous vein or the superficial femoral vein [9]
whereas transfemoral and transiliac approaches have also
been described [24]. One must however bear in mind both
the general complications of CPB as well as specific com-
plications including pericardial tamponade, haemothorax
or pneumothorax, thrombo-embolism, peripheral lead
escape or wound infection.
In terms of diagnosis, along with clinical suspicion, we
used TEE to investigate the underlying cause for the pa-
tient’s symptoms. Ultrasonography for detection of severeinnominate vein or SVC stenosis using sonography, pulse
Doppler and colour flow have been shown to be accurate,
and are useful for follow-up [25]. Contrast venography is
considered to be the gold-standard for detecting venous
obstruction but has drawbacks in terms of being invasive
and inducing contrast nephropathy [26]. Spiral CT uses
less contrast and benefits from excluding other causes of
SVC obstruction [26]. Magnetic resonance imaging is also
non-invasive but is a contra-indication in patients with
pacemakers or implantable cardioverter defibrillator
(ICD).
Our case has shown the safe approach for diagnosis and
management of SVC syndrome caused by pacemaker lead
thrombosis and infection. Although our approach of car-
diopulmonary bypass and cardiac arrest is an invasive and
technically challenging surgical procedure, it allows direct
visualisation of the vegetations and the extent of disease.
Our approach of innominate vein cannulation highlights a
strategy for overcoming the problem of extensive disease
within the SVC. Due to the heterogeneous nature of
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be based upon clinical diagnosis and imaging. There is a
lack of large multi-centre data to support one intervention
over another. Future studies should therefore compare
practices and provide long-term efficacies associated with
cardiopulmonary bypass in the context of managing SVC
syndrome from pacemaker lead infection and thrombosis.
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